These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

808 related items for PubMed ID: 17167719

  • 1. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T, Babusíková O.
    Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
    [Abstract] [Full Text] [Related]

  • 2. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
    Zelezníková T, Babusíková O.
    Neoplasma; 2005; 52(6):517-22. PubMed ID: 16284699
    [Abstract] [Full Text] [Related]

  • 3. Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring.
    Langebrake C, Brinkmann I, Teigler-Schlegel A, Creutzig U, Griesinger F, Puhlmann U, Reinhardt D.
    Cytometry B Clin Cytom; 2005 Jan; 63(1):1-9. PubMed ID: 15624201
    [Abstract] [Full Text] [Related]

  • 4. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [Abstract] [Full Text] [Related]

  • 5. Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.
    Kern W, Danhauser-Riedl S, Ratei R, Schnittger S, Schoch C, Kolb HJ, Ludwig WD, Hiddemann W, Haferlach T.
    Haematologica; 2003 Jun; 88(6):646-53. PubMed ID: 12801840
    [Abstract] [Full Text] [Related]

  • 6. Immunological evaluation of minimal residual disease (MRD) in acute myeloid leukaemia (AML).
    San-Miguel JF, Vidriales MB, Orfão A.
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):105-18. PubMed ID: 11987919
    [Abstract] [Full Text] [Related]

  • 7. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
    Al-Mawali A, Gillis D, Hissaria P, Lewis I.
    Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies.
    Macedo A, Orfão A, Gonzalez M, Vidriales MB, López-Berges MC, Martínez A, San Miguel JF.
    Leukemia; 1995 Jun; 9(6):993-8. PubMed ID: 7596191
    [Abstract] [Full Text] [Related]

  • 16. Phenotypic quantitative features of patients with acute myeloid leukemia.
    Pereira FG, Metze K, Costa FP, Lima CS, Lorand-Metze I.
    Neoplasma; 2006 Jun; 53(2):155-60. PubMed ID: 16575472
    [Abstract] [Full Text] [Related]

  • 17. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J, Orfao A, Vidriales B, Macedo A, Martínez A, González M, López-Berges MC, Valverde B, San Miguel JF.
    Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
    [Abstract] [Full Text] [Related]

  • 18. Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden.
    Feller N, Jansen-van der Weide MC, van der Pol MA, Westra GA, Ossenkoppele GJ, Schuurhuis GJ.
    Exp Hematol; 2005 Jan; 33(1):120-30. PubMed ID: 15661405
    [Abstract] [Full Text] [Related]

  • 19. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
    Olaru D, Campos L, Flandrin P, Nadal N, Duval A, Chautard S, Guyotat D.
    Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
    [Abstract] [Full Text] [Related]

  • 20. Shifts in expression of immunological cell markers in relapsed acute leukemia.
    Tomová A, Babusíková O.
    Neoplasma; 2001 Jan; 48(3):164-8. PubMed ID: 11583283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.